These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 26417370)

  • 1. Evaluation of AgNORs in Oral Potentially Malignant Lesions.
    Tomazelli KB; Modolo F; Rivero ER
    J Oncol; 2015; 2015():218280. PubMed ID: 26417370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of cell proliferation rate in non-dysplastic leukoplakias.
    Hildebrand LD; Carrard VC; Lauxen ID; de Quadros OF; Chaves AC; Sant' Ana-Filho M
    Med Oral Patol Oral Cir Bucal; 2010 Mar; 15(2):e328-34. PubMed ID: 19767704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of human telomerase reverse transcriptase protein in oral epithelial dysplasia and oral squamous cell carcinoma: An immunohistochemical study.
    Raghunandan BN; Sanjai K; Kumaraswamy J; Papaiah L; Pandey B; Jyothi BM
    J Oral Maxillofac Pathol; 2016; 20(1):96-101. PubMed ID: 27194869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suprabasal expression of Ki-67 as a marker for the severity of oral epithelial dysplasia and oral squamous cell carcinoma.
    Dwivedi N; Chandra S; Kashyap B; Raj V; Agarwal A
    Contemp Clin Dent; 2013 Jan; 4(1):7-12. PubMed ID: 23853445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of cell proliferation in malignant and potentially malignant oral lesions.
    Madan M; Chandra S; Raj V; Madan R
    J Oral Maxillofac Pathol; 2015; 19(3):297-305. PubMed ID: 26980956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Langerhans cells and T cells sense cell dysplasia in oral leukoplakias and oral squamous cell carcinomas--evidence for immunosurveillance.
    Öhman J; Magnusson B; Telemo E; Jontell M; Hasséus B
    Scand J Immunol; 2012 Jul; 76(1):39-48. PubMed ID: 22469080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of p53 in oral mucosal hyperplasia, dysplasia and squamous cell carcinoma.
    Kerdpon D; Rich AM; Reade PC
    Oral Dis; 1997 Jun; 3(2):86-92. PubMed ID: 9467348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative estimation of AgNORs in normal, dysplastic and malignant oral mucosa.
    Chowdhry A; Deshmukh RS; Shukla D; Bablani D; Mishra S
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2014 Jun; 158(2):282-7. PubMed ID: 23446205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minor Salivary Gland Changes in Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma - A Histopathological Study.
    Mohan SP; Chitturi RT; Ragunathan YT; Lakshmi SJ; Nallusamy J; Joseph I
    J Clin Diagn Res; 2016 Jul; 10(7):ZC12-5. PubMed ID: 27630945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the expression of p53, MDM2, and SUMO-1 in oral lichen planus.
    Oliveira Alves M; Balducci I; Rodarte Carvalho Y; Cabral L; Nunes F; Almeida J
    Oral Dis; 2013 Nov; 19(8):775-80. PubMed ID: 23350884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histomorphometric Analysis of Angiogenesis using CD31 Immunomarker and Mast Cell Density in Oral Premalignant and Malignant Lesions: A Pilot Study.
    Jyothsna M; Rammanohar M; Kumar K
    J Clin Diagn Res; 2017 Jan; 11(1):ZC37-ZC40. PubMed ID: 28274041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Determination of human papillomavirus in oral leukoplakia,oral lichen planus and oral squamous cell carcinoma].
    Cao J; Jin JQ; Deng DJ; Liu HW
    Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Feb; 48(1):84-8. PubMed ID: 26885914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term treatment outcome of oral premalignant lesions.
    Holmstrup P; Vedtofte P; Reibel J; Stoltze K
    Oral Oncol; 2006 May; 42(5):461-74. PubMed ID: 16316774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ki-67 Prognostic Value in Different Histological Grades of Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma.
    Takkem A; Barakat C; Zakaraia S; Zaid K; Najmeh J; Ayoub M; Seirawan MY
    Asian Pac J Cancer Prev; 2018 Nov; 19(11):3279-3286. PubMed ID: 30486632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical study of integrin α₅β₁, fibronectin, and Bcl-2 in normal oral mucosa, inflammatory fibroepithelial hyperplasia, oral epithelial dysplasia, and oral squamous cell carcinoma.
    Núñez MA; de Matos FR; Freitas Rde A; Galvão HC
    Appl Immunohistochem Mol Morphol; 2013 Jul; 21(4):354-61. PubMed ID: 23235343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proliferating activity in oral dysplastic leasions and squamous cell carcinomas.
    Sulkowska M; Famulski W; Kasacka I; Stasiak-Barmuta A; Sulkowski S; Miller-Famulska D; Koda M
    Folia Histochem Cytobiol; 2001; 39 Suppl 2():191-2. PubMed ID: 11820602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Caveolin-1 expression in oral lichen planus, dysplastic lesions and squamous cell carcinoma.
    Jaafari-Ashkavandi Z; Aslani E
    Pathol Res Pract; 2017 Jul; 213(7):809-814. PubMed ID: 28554768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MCM-2 expression differentiates potentially malignant verrucous lesions from oral carcinomas.
    Niranjan KC; Sarathy NA; Alrani D
    Ann Diagn Pathol; 2018 Jun; 34():72-76. PubMed ID: 29661732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AgNORs in duct epithelial lesions in chronic pancreatitis and in pancreas cancer cells.
    Cylwik B; Nowak HF; Puchalski Z; Zimnoch L; Dadan J
    Hepatogastroenterology; 1998; 45(22):1130-4. PubMed ID: 9756019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can quantifying free-circulating DNA be a diagnostic and prognostic marker in oral epithelial dysplasia and oral squamous cell carcinoma?
    Shukla D; Kale AD; Hallikerimath S; Yerramalla V; Subbiah V
    J Oral Maxillofac Surg; 2013 Feb; 71(2):414-8. PubMed ID: 22749518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.